393 related articles for article (PubMed ID: 31155978)
1. Prescribing issues in elderly individuals living with HIV.
Marzolini C; Livio F
Expert Rev Clin Pharmacol; 2019 Jul; 12(7):643-659. PubMed ID: 31155978
[No Abstract] [Full Text] [Related]
2. The challenge of HIV treatment in an era of polypharmacy.
Back D; Marzolini C
J Int AIDS Soc; 2020 Feb; 23(2):e25449. PubMed ID: 32011104
[TBL] [Abstract][Full Text] [Related]
3. Managing antiretroviral therapy in the elderly HIV patient.
Guaraldi G; Pintassilgo I; Milic J; Mussini C
Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1171-1181. PubMed ID: 30444968
[No Abstract] [Full Text] [Related]
4. Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection.
Greene M; Steinman MA; McNicholl IR; Valcour V
J Am Geriatr Soc; 2014 Mar; 62(3):447-53. PubMed ID: 24576251
[TBL] [Abstract][Full Text] [Related]
5. Analysis of inappropriate prescribing in elderly patients of the Swiss HIV Cohort Study reveals gender inequity.
Livio F; Deutschmann E; Moffa G; Rrustemi F; Stader F; Elzi L; Braun DL; Calmy A; Hachfeld A; Cavassini M; Tarr PE; Wissel K; Battegay M; Marzolini C;
J Antimicrob Chemother; 2021 Feb; 76(3):758-764. PubMed ID: 33279997
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of old age.
Koren G; Nordon G; Radinsky K; Shalev V
Expert Rev Clin Pharmacol; 2019 Aug; 12(8):749-755. PubMed ID: 31232610
[No Abstract] [Full Text] [Related]
7. Is my older cancer patient on too many medications?
Turner JP; Shakib S; Bell JS
J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102
[TBL] [Abstract][Full Text] [Related]
8. [Polymedication among elderly patients Preventing drug related problems and inappropriate medication].
Patris S
J Pharm Belg; 2016 Sep; (3):4-9. PubMed ID: 30281238
[TBL] [Abstract][Full Text] [Related]
9. [Good prescribing practice in the elderly].
Wickop B; Langebrake C
Ther Umsch; 2014 Jun; 71(6):366-73. PubMed ID: 24867351
[TBL] [Abstract][Full Text] [Related]
10. A multi-center, randomized, controlled trial to assess the efficacy of optimization of drug prescribing in an elderly population, at 18 months of follow-up, in the evolution of functional autonomy: the OPTIM study protocol.
Dauphinot V; Jean-Bart E; Krolak-Salmon P; Mouchoux C
BMC Geriatr; 2017 Aug; 17(1):195. PubMed ID: 28854884
[TBL] [Abstract][Full Text] [Related]
11. The Fit fOR The Aged (FORTA) project and its clinical implications.
Pazan F; Wehling M
Expert Opin Drug Metab Toxicol; 2020 Apr; 16(4):275-277. PubMed ID: 32163717
[No Abstract] [Full Text] [Related]
12. Deprescribing medications in older people: a narrative review.
Salahudeen MS
Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
[TBL] [Abstract][Full Text] [Related]
13. Clinical consequences of polypharmacy in elderly.
Maher RL; Hanlon J; Hajjar ER
Expert Opin Drug Saf; 2014 Jan; 13(1):57-65. PubMed ID: 24073682
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between geriatricians and general practitioners for improved pharmacotherapy in home-dwelling elderly people receiving polypharmacy - the COOP Study: study protocol for a cluster randomised controlled trial.
Romskaug R; Molden E; Straand J; Kersten H; Skovlund E; Pitkala KH; Wyller TB
Trials; 2017 Apr; 18(1):158. PubMed ID: 28372591
[TBL] [Abstract][Full Text] [Related]
15. Methods to control the pharmaceutical cost impact of chronic conditions in the elderly.
Vivas-Consuelo D; Usó-Talamantes R; Trillo-Mata JL; Mendez-Valera P
Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):425-37. PubMed ID: 25703585
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of medicines review with web-based pharmaceutical treatment algorithms in reducing potentially inappropriate prescribing in older people in primary care: a cluster randomized trial (OPTI-SCRIPT study protocol).
Clyne B; Bradley MC; Smith SM; Hughes CM; Motterlini N; Clear D; McDonnell R; Williams D; Fahey T;
Trials; 2013 Mar; 14():72. PubMed ID: 23497575
[TBL] [Abstract][Full Text] [Related]
17. [Impact of Geriatric Drug Guidelines on the Quality Requirement of Elderly Patients].
Fauvelle F; Kabirian F; Domingues A; Tubach F; Gault N; Abbas R
Therapie; 2015; 70(6):515-21. PubMed ID: 26242496
[TBL] [Abstract][Full Text] [Related]
18. Prescribing in 2019: what are the safety concerns?
Coleman JJ
Expert Opin Drug Saf; 2019 Feb; 18(2):69-74. PubMed ID: 30657340
[TBL] [Abstract][Full Text] [Related]
19. Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long-term care facilities) of the Friuli Venezia Giulia region, Italy: are the very elderly at higher risk of PIPs?
Cojutti P; Arnoldo L; Cattani G; Brusaferro S; Pea F
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1070-8. PubMed ID: 27184012
[TBL] [Abstract][Full Text] [Related]
20. Prioritizing interventions to manage polypharmacy in Australian aged care facilities.
Jokanovic N; Wang KN; Dooley MJ; Lalic S; Tan EC; Kirkpatrick CM; Bell JS
Res Social Adm Pharm; 2017; 13(3):564-574. PubMed ID: 27374998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
